Contents

SynopsisCodesLook ForDiagnostic PearlsDifferential Diagnosis & PitfallsBest TestsManagement PearlsTherapyDrug Reaction DataReferences

Information for Patients

View all Images (10)

Emergency: requires immediate attention
Giant cell arteritis
Other Resources UpToDate PubMed
Emergency: requires immediate attention

Giant cell arteritis

Contributors: Michael W. Winter MD, Ryan Hoefen MD, PhD, Susan Burgin MD, Paritosh Prasad MD
Other Resources UpToDate PubMed

Synopsis

Giant cell arteritis (GCA) is a systemic vasculitis affecting medium- to large-sized arteries, including the aorta and the extracranial branches of the carotid artery. GCA is rarely found in individuals younger than 55, and the mean age for disease presentation is 76.

Patients may present with systemic symptoms such as a new temporal headache, fever, anorexia, weight loss, morning stiffness in the shoulder or neck, myalgia, fatigue, and anemia. There may be elevated ESR or C-reactive protein, temporal artery tenderness to palpation, or decreased arterial pulsation unrelated to arteriosclerosis. Patients may have scalp tenderness, visual disturbances (amaurosis fugax), jaw or tongue claudication or difficulty chewing, or upper cranial palsies.

GCA and polymyalgia rheumatica (PMR) have a significant clinical association: 16%-21% of cases of PMR are associated with GCA, and 40%-60% of patients diagnosed with GCA also have PMR.

The most serious complication of GCA is sudden blindness, a result of anterior ischemic optic neuropathy caused by ischemia secondary to inflammation of the ophthalmic artery supplying the optic nerve. Some patients may experience transient vision loss. All patients with suspected GCA should have temporal artery biopsy. Pathologic findings include a predominance of mononuclear cell infiltration or granulomatous inflammation, usually with multinucleated giant cells.

Scalp necrosis is a rare but potentially life-threatening complication.

The 2022 American College of Rheumatology (ACR) / European Alliance of Associations for Rheumatology (EULAR) classification criteria for GCA when a diagnosis of medium-vessel or large-vessel vasculitis has been made:

A patient aged 50 years or older; 6 or more of the following points are needed for diagnosis:

Clinical criteria
  • Morning stiffness in the shoulders or neck, jaw or tongue claudication, new temporal headache, scalp tenderness, abnormal clinical examination of the temporal artery (such as diminished pulse, tenderness, or a hard, cord-like texture) (+2 each)
  • Sudden visual loss (+3)
Laboratory, imaging, and biopsy criteria
  • ESR ≥ 50 mm/hour or C-reactive protein ≥ 10 mg/L (+3)
  • Positive temporal artery biopsy or temporal artery halo sign on ultrasound (+5)
  • Bilateral axillary luminal damage (as seen on angiography, ultrasound, or fluorodeoxyglucose-positron emission tomography [FDG-PET]; +2)
  • FDG-PET uptake throughout the aorta (+2)

Codes

ICD10CM:
M31.6 – Other giant cell arteritis

SNOMEDCT:
400130008 – Temporal arteritis

Look For

Subscription Required

Diagnostic Pearls

Subscription Required

Differential Diagnosis & Pitfalls

Best Tests

Subscription Required

Management Pearls

Subscription Required

Therapy

Subscription Required

Drug Reaction Data

Below is a list of drugs with literature evidence indicating an adverse association with this diagnosis. The list is continually updated through ongoing research and new medication approvals. Click on Citations to sort by number of citations or click on Medication to sort the medications alphabetically.

Subscription Required

References

Subscription Required

Last Reviewed:02/25/2019
Last Updated:02/08/2023
Copyright © 2023 VisualDx®. All rights reserved.
Emergency: requires immediate attention
Patient Information for Giant cell arteritis
Print E-Mail Images (10)
Contributors: Medical staff writer

Overview

Giant cell arteritis, or temporal arteritis, is inflammation of the lining of the arteries. It typically affects the head and causes frequent headaches. It is most common among people over the age of 50. If left untreated, giant cell arteritis can lead to more serious conditions, including loss of vision and stroke.

Who’s At Risk

Risk factors include:
  • Age over 50
  • Women are twice as likely to develop giant cell arteritis
  • Most common among whites in Northern Europe and of Scandinavian descent
  • The condition polymyalgia rheumatica increases your risk of developing giant cell arteritis
  • Family history of giant cell arteritis

Signs & Symptoms

The most common symptom of giant cell arteritis is a severe headache on both sides of the head on the temples. Other symptoms can include:
  • Scalp tenderness
  • Neck pain and jaw pain especially when opening the mouth
  • Fever
  • Muscle ache and fatigue
  • Loss of appetite and weight loss
  • Impaired vision
  • Sudden loss of vision in one eye

Self-Care Guidelines

Discuss side effects of medications used to treat giant cell arteritis with your health care provider. Schedule regular doctor visits.

Your doctor may recommend daily aspirin to reduce your risk of stroke.

When to Seek Medical Care

Contact your health care provider if you develop a persistent headache or have any of the symptoms listed above, as treatment should be started as soon as possible.

Treatments

A high dose of corticosteroids (prednisone) is the treatment for giant cell arteritis. Symptoms should improve within a few days of starting treatment. Your health care provider will slowly reduce the dosage depending on your symptoms. Treatment with corticosteroids may last one to two years.
Copyright © 2023 VisualDx®. All rights reserved.
Emergency: requires immediate attention
Giant cell arteritis
A medical illustration showing key findings of Giant cell arteritis
Copyright © 2023 VisualDx®. All rights reserved.